Table 2.
Transmitter | innervation pattern | References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
np | PRM | PP | PE | VD | pace. | PG | SD | HD | SV | OO | ||
APGW | + | + | + | + | + | + | Van Golen et al. (1995a,b); Van Kesteren et al. (1992); De Lange et al. (1998a) | |||||
Conopressin | + | + | + | + | + | Van Golen et al. (1995a,b); Van Kesteren et al. (1992) | ||||||
C-terminally located anterior lobe peptide (CALP) | ||||||||||||
DEILSR | + | + | De Lange et al. (1998a) | |||||||||
EFLRI | + | + | + | Bright et al. (1993); Santama et al. (1993, 1995); Van Golen et al. (1995a,b) | ||||||||
FLRF | + | + | + | Bright et al. (1993); Santama et al. (1993, 1995); Van Golen et al. (1995a,b) | ||||||||
FMRF | + | + | + | + | + | + | + | Schott and Boer (1982); Bright et al. (1993); Santama et al. (1993, 1995); Van Golen et al. (1995a,b); De Lange et al. (1997, 1998a) | ||||
FVRIs | + | + | + | El Filali et al. (2006) | ||||||||
G/SDPFLRF | ||||||||||||
Gonadotropin releasing hormone (GnRH) | + | Young et al. (1999) | ||||||||||
Lymnaea inhibitory peptides (LIP A, B, C) | + | + | + | + | + | + | Smit et al. (2003); De Lange et al. (1998a) | |||||
Lymnaea neuopeptide Y (LyNPY) | + | + | De Lange et al. (1997) | |||||||||
Myomodulins | + | + | Li et al. (1994a,b) | |||||||||
Pedal peptide (PP) | + | De Lange et al. (1998a) | ||||||||||
pQFYRI | + | + | + | Bright et al. (1993); Santama et al. (1993, 1995); Van Golen et al. (1995a,b) | ||||||||
SEEPLY | + | + | + | Bright et al. (1993); Santama et al. (1993, 1995); Van Golen et al. (1995a,b); De Lange et al. (1998a) | ||||||||
Serotonin (5HT) | + | + | + | Croll and Chiasson (1989) |
HD, hermaphroditic duct; np, nervus penis; OO, oothecal gland; pace, pacemaker area of vas deferens; PE, penis; PG, prostate gland; PP, preputium; PRM, preputial retractor muscle; SD, sperm duct; SV, seminal vesicles; VD, vas deferens. Locations with a plus (+) indicate that nerve fibers containing thetransmitter have been detected